
The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

After sparking a wave of concern through industry and mainstream media with the news it had halted international studies investigating …

Interim Phase 1/2 findings have been released for the COVID-19 highly anticipated vaccine candidate in development from Oxford University and …

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …